Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Know Labs Inc (KNWN)

Know Labs Inc (KNWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 110,989
  • Shares Outstanding, K 43,869
  • Annual Sales, $ 0 K
  • Annual Income, $ -25,360 K
  • 60-Month Beta 2.40
  • Price/Sales 25.46
  • Price/Cash Flow N/A
  • Price/Book 22.55
Trade KNWN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.76
  • Most Recent Earnings $-0.07 on 08/12/22
  • Latest Earnings Date 08/22/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.00
  • Number of Estimates 1
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year -0.22
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.9500 +29.74%
on 08/31/22
4.0000 -36.75%
on 09/06/22
+0.0800 (+3.27%)
since 08/15/22
3-Month
1.5000 +68.67%
on 06/22/22
4.0000 -36.75%
on 09/06/22
+0.8400 (+49.70%)
since 06/15/22
52-Week
1.1500 +120.00%
on 06/14/22
4.0000 -36.75%
on 09/06/22
+0.0300 (+1.20%)
since 09/15/21

Most Recent Stories

More News
Know Labs, Inc. Announces NYSE American Listing Approval

Know Labs, Inc. (OTCQB: KNWN), an emerging leader of non-invasive medical diagnostic technology, today announced that, subject to official authorization and meeting all requirements (including the price...

KNWN : 2.5300 (-3.44%)
Know Labs Provides Update on IRB-Approved Internal Trial of Non-Invasive Glucose Monitoring Technology

Know Labs, Inc. (OTCQB: KNWN) , an emerging developer of non-invasive medical diagnostic technology, today released a video update on the IRB-approved internal trial the Company has been conducting at...

KNWN : 2.5300 (-3.44%)
Know Labs Files S-1 for New Share Offering, Seeks Uplist to NYSE American Exchange

Know Labs, Inc. (OTCQB: KNWN) an emerging developer of non-invasive medical diagnostic technology, today announced it has filed a Form S-1 registration statement for a proposed new offering of 3 million...

KNWN : 2.5300 (-3.44%)
Know Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA Clearance Application

Know Labs, Inc. (OTCQB: KNWN) , an emerging leader in non-invasive medical diagnostic technology, today announced the addition of two senior executives, each of whom will play a pivotal role in guiding...

KNWN : 2.5300 (-3.44%)
New Foundational Patents Secure Multiple Growth Opportunities for Know Labs and Its Bio-RFID™ Non-Invasive Diagnostic Technology

Know Labs, Inc. (OTCQB: KNWN) , an emerging leader in non-invasive medical diagnostics, today announced it has been granted two new foundational patents that add significant value to its IP portfolio and...

KNWN : 2.5300 (-3.44%)
Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced it has received approval from an independent Institutional Review Board (IRB) for the protocol of...

KNWN : 2.5300 (-3.44%)
Know Labs Launches Subsidiary, AI Mind Inc., Generates $4.2M in NFT Revenue to Fund Continued Non-Invasive Glucose Monitoring Device Development

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that a new subsidiary created to work with the company’s Artificial Intelligence (AI) Deep Learning...

KNWN : 2.5300 (-3.44%)
New Test Data Confirm Particle™ Bulb from Know Labs Successfully Inactivates SARS-CoV-2 Variants

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that new independent test data have confirmed the efficacy of a light bulb produced by its wholly...

KNWN : 2.5300 (-3.44%)
New Tests Show Know Labs Bio-RFID™ Technology Delivers Blood Glucose Readings Comparable to FDA-Cleared Devices

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today published a new report on its non-invasive platform technology, Bio-RFID TM , comparing its clinical accuracy...

KNWN : 2.5300 (-3.44%)
Know Labs Expands Non-Invasive Glucose Monitoring Product Portfolio with Introduction of New KnowU™ Diagnostic Device

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today introduced the KnowU™, a new portable medical-grade glucose monitoring device that utilizes Bio-RFID™, Know...

KNWN : 2.5300 (-3.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Know Labs Inc. technology directs structured light or radio waves through a substance or material to capture a unique molecular signature. The Company refers to these signatures as ChromaID(TM) and Bio-RFID(TM). ChromaID and Bio-RFID are used to identify, detect, or diagnose substance markers or biomarkers...

See More

Key Turning Points

3rd Resistance Point 3.0033
2nd Resistance Point 2.8767
1st Resistance Point 2.7033
Last Price 2.5300
1st Support Level 2.4033
2nd Support Level 2.2767
3rd Support Level 2.1033

See More

52-Week High 4.0000
Fibonacci 61.8% 2.9113
Fibonacci 50% 2.5750
Last Price 2.5300
Fibonacci 38.2% 2.2387
52-Week Low 1.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar